Stay updated with breaking news from Mark Einstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A quality-control crisis at an Indian pharmaceutical factory has left doctors and their patients with impossible choices as cheap, effective, generic cancer drugs go out of stock.
A quality-control crisis at an Indian pharmaceutical factory has left doctors and their patients with impossible choices as cheap, effective, generic cancer drugs go out of stock.
Doctors and their patients are facing the unimaginable: They are being forced into grim contemplation of untested rationing plans for breast, cervical, bladder, ovarian, lung, and other cancers.
A quality-control crisis at an Indian pharmaceutical factory has left doctors and their patients with impossible choices as cheap, effective, generic cancer drugs go out of stock.
Scores of drugs to treat cancer, cardiovascular disease and other ailments are in shortage, and experts agree the main cause is the underlying weakness of the generic drug industry.